Dual antiplatelet therapy with cilostazol in stroke patients with extracranial arterial stenosis or without arterial stenosis: A subgroup analysis of the CSPS.com trial
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Stroke"
DOI: 10.1177/17474930221112343
Abstract: Background: We previously reported that dual antiplatelet therapy (DAPT) with cilostazol was superior to aspirin or clopidogrel for the prevention of recurrent stroke and vascular events in a subgroup analysis of intracranial arterial stenosis in… read more here.
Keywords: cilostazol; without arterial; subgroup analysis; antiplatelet ... See more keywords